RSS
#10. Substance Use
- Three Buprenorphine Dosing Strategies When Transitioning From Other Opioids — The Carlat Addiction Treatment Report (April 2024)
- Addiction Through the Decades: From DSM-I to DSM-5 — The Carlat Addiction Treatment Report (June 2013)
- Effective Management of Buprenorphine-Precipitated Opioid Withdrawal — The Carlat Addiction Treatment Report (January 2025)
- Topiramate Versus Naltrexone for Alcohol Use Disorder — The Carlat Psychiatry Report (August 2025)
- CME Post-Test, Addiction, TCPR, October 2024 — The Carlat Psychiatry Report (September 2024)
#9. Sleep Disorders
- Non-Addictive, Pharmacological Options for Sleep — The Carlat Addiction Treatment Report (August 2018)
- Prescribing Medications for Sleep Disorders in Older Adults — The Carlat Geriatric Psychiatry Report (June 2025)
- New Medications for Insomnia — The Carlat Psychiatry Report (February 2024)
- Sleep and Senescence: Managing Sleep Disorders in Older Adults — The Carlat Geriatric Psychiatry Report (April 2025)
- Insomnia and Sleep Medications — The Carlat Geriatric Psychiatry Report (April 2025)
#8. Drug Interactions & Safety
- QT Intervals in Psychiatric Practice — The Carlat Hospital Psychiatry Report (October 2022)
- Drug Interactions That Matter — The Carlat Psychiatry Report (September 2025)
- Interpreting Urine Drug Tests — The Carlat Hospital Psychiatry Report (April 2023)
- Treating Sexual Side Effects — The Carlat Psychiatry Report (May 2019)
- Comparing Side Effect Sizes With a Free New Tool — The Carlat Psychiatry Report (June 2025)
#7. Child & Adolescent
- Childhood Sexual Behavior: What’s Normal and What’s Not — The Carlat Child Psychiatry Report (December 2013)
- Dissociative Identity Disorder vs Plural Identity in Teens and Young Adults — The Carlat Child Psychiatry Report (August 2023)
- Tourette’s Syndrome: A Brief Summary — The Carlat Child Psychiatry Report (June 2011)
- Assessing and Treating Catatonia in Children and Adolescents — The Carlat Child Psychiatry Report (October 2022)
- CME Post-Test, Substance Use in Children and Adolescents, CCPR, January/February/March 2025 — The Carlat Child Psychiatry Report (January 2025)
#6. Bipolar Disorder
- Lithium Orotate — The Carlat Psychiatry Report (August 2025)
- Low-Dose Lithium to Delay Dementia? — The Carlat Psychiatry Report (September 2022)
- Mood Stabilizers for Bipolar Disorder in Older Adults: Special Considerations — The Carlat Geriatric Psychiatry Report (January 2023)
- Mania in Older Adults — The Carlat Geriatric Psychiatry Report (January 2023)
- Lithium for Children and Adolescents — The Carlat Child Psychiatry Report (November 2023)
#5. Medication Guides
- An Off-Label Guide to Gabapentin — The Carlat Psychiatry Report (January 2022)
- Medication Fact Book for Psychiatric Practice, Seventh Edition (2022) — Medication Fact Book Seventh Edition (2024) (April 2022)
- The New Billing Codes — The Carlat Psychiatry Report (January 2022)
- Medication Fact Book for Psychiatric Practice, Seventh Edition (2022) — Medication Fact Book Seventh Edition (2024) (April 2022)
- How to Stop a Psychiatric Med — The Carlat Psychiatry Report (November 2024)
#4. Anxiety & Benzodiazepines
- Benzodiazepines: The Basics and Beyond — The Carlat Addiction Treatment Report (October 2023)
- Silexan: A Novel Anxiolytic — The Carlat Psychiatry Report (July 2020)
- Buspirone: Still Effective After All These Years? — The Carlat Psychiatry Report (February 2021)
- Managing Treatment-Resistant Anxiety Disorders in Older Adults — The Carlat Geriatric Psychiatry Report (January 2025)
- Benzodiazepines — The Carlat Psychiatry Report (May 2025)
#3. Antipsychotics
- Medications to Rapidly Treat Psychotic Agitation — The Carlat Hospital Psychiatry Report (September 2021)
- Vitamin B6 Lowers Prolactin on Antipsychotics — The Carlat Psychiatry Report (March 2022)
- Akathisia: Manifestations and Treatment — The Carlat Hospital Psychiatry Report (January 2025)
- Quetiapine Reconsidered — The Carlat Psychiatry Report (June 2022)
- Ask the Editor: Which Antipsychotic Is Best When Patients Complain of Akathisia? — The Carlat Psychiatry Report (November 2018)
#2. Antidepressants
- l-Methylfolate for Depression: Costly Mistake or Good Thinking? — The Carlat Psychiatry Report (August 2019)
- Viibryd Goes Generic, But Is It Worth Prescribing? — The Carlat Psychiatry Report (January 2023)
- Comparison of GI Side Effects of Antidepressants — The Carlat Psychiatry Report (August 2021)
- Mirtazapine Augmentation: Running Low on Rocket Fuel — The Carlat Psychiatry Report (August 2019)
- Antidepressants: When Dosage Matters — The Carlat Psychiatry Report (April 2022)
#1. ADHD & Stimulants
- Stimulant Dosing Limits — The Carlat Psychiatry Report (August 2023)
- Vyvanse Goes Generic: An Amphetamine Apart — The Carlat Psychiatry Report (November 2024)
- The Benzodiazepine-Stimulant Combo: What Could Go Wrong? — The Carlat Psychiatry Report (September 2022)
- Ask the Editor: Three Significant Food Interactions with ADHD Medications — The Carlat Psychiatry Report (October 2018)
- Adult ADHD: Comprehensive Diagnosis and Treatment Audio Course — Adullt ADHD Audio Course (March 2025)
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.webp?t=1729528747 "KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg")
